Press release
Tharimmune is the first publicly traded company supporting the Canton Network and leveraging Canton Coin. Our goal is to advance institutional blockchain adoption and drive the digitization of financial markets.
Tharimmune is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development.
